PiùMedical S.p.A. (BIT:PMED)
Italy · Delayed Price · Currency is EUR 5.55
+0.10 (1.83%)
At close: Nov 6, 2026
PiùMedical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, PiùMedical stock has an average price target of €7.85. The average 1-year stock price forecast is 41.44% higher than the current stock price, while the lowest is €7.50 (+35.14%) and the highest is €8.20 (+47.75%).
Price Target: €7.85 (+41.44%)
Analyst Consensus: n/a
Price Target
Chart* Price targets were last updated on Oct 2, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for PiùMedical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TP ICAP MIDCAP | TP ICAP MIDCAP | Buy Maintains €8.20 | Buy | Maintains | €8.20 | +47.75% | Oct 2, 2026 |
Financial Forecast
Revenue This Year
54.55M
from 6.64M
Increased by 720.94%
Revenue Next Year
58.65M
from 54.55M
Increased by 7.52%
EPS This Year
0.18
EPS Next Year
0.27
from 0.18
Increased by 47.22%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.